Ortho-clinical Diagnostics, Inc

Praxair Technology, Inc.

The Penn State Research Foundation

Grifols Worldwide Operations Limited

Jian Zheng

Jianping Yang

Neil Andrew Stephenson

Philip Alexander Barrett

George Bashirians

Renee Yura

Steven John Pontonio

Banumathi Sankaran

David Y Chien

Angelica Medina-Selby

Doris Guenzi Coit

Edward R Scalice

John Andrew Hall

John W Backus

Alexander Gyenes

Deborah Byrne

Sarah Groulx

Sharon Jackson

Toshiya Fujihara

Heather Lane-Brown

Karen Yang

Steve Stanley Alexander

Stephen Daggett

James J Strohm

Chunshan Song

Xiaoxing Wang

Brett Hirsch

Chao Xie

Christopher D Schotz

Robert De Leys

Weidong Gu

Qi Sun

An antigen with an increased half-life is provided for the formulation of more stable and consistent clinical diagnostic immunoassay controls and calibrators. An antigen analogue comprises a first and a second polypeptide which is identical or similar to corresponding terminal amino acid sequences of an antigen. The first and second polypeptides are connected with a PEG chain. Also provided are methods of calibrating assays using a compound disclosed herein.

Antigen analogue for calibration of immunometric diagnostic assays

The present disclosure is directed to a thin-film element that enables analytes to be analyzed on separate surfaces. In an example, a thin-film element includes a first layer for processing a fluid sample to generate a first analyte and a second analyte. The thin-film element also includes a second layer configured to be impermeable to the first analyte to enable the first analyte to be retained by the first layer and permeable to the second analyte to enable the second analyte to pass through the second layer. The thin-film element further includes a third layer configured to retain the second analyte. The second layer includes a first reflective surface and a second reflective surface to provide reflectance signals indicative of analytes present in the first and third layers to sensors located on opposite sides of the thin-film element.

Dual-sensor detection of reflectance signals for thin-film based assays

Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.

HCV NS4a/modified NS3 polypeptides and uses thereof

The present invention relates generally to an attrition resistant core-in-shell composite adsorbent comprising at least a zeolite-containing COremoval adsorbent and a binder on an inert dense core. The attrition resistant core-in-shell composite adsorbent has an attrition loss of less than about 2 wt %. The core-in-shell composite adsorbent is preferably used in a multi-layered adsorption system in a cyclic adsorption process, preferably used in a PSA prepurification process prior to cryogenic air separation.

Core-in-shell composite adsorbent for use in PSA prepurifiers

HCV NS4A/modified NS3 polypeptides and uses thereof

Atriplet antigen construct is disclosed which includes threeantigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.

Treponema pallidum triplet antigen

The present invention is directed to combination immunoassays, reagents and kits for simultaneous detection of HCV antigens and anti-HCV antibodies in a sample. The combination immunoassays of the present invention employ a non-ionic detergent that effectively exposes or releases the HCV core antigen from virions in a sample without interfering with the performance of other reagents such as the capture of anti-HCV antibodies by recombinant HCV antigens.

Reagents for HCV antigen-antibody combination assays

The invention relates to novel bimetallic and trimetallic catalysts, their manufacture and use in both steam reforming and oxidative steam reforming of liquid fuels such as jet fuels, diesel fuels and gasoline to produce synthesis gas and/or hydrogen for fuel cell applications. The invention further relates to manufacture of synthesis gas and/or hydrogen gas for chemicals synthesis and fuel processing. The catalysts have high sulfur tolerance and carbon resistance when used in steam reforming and/or oxidative steam reforming of heavy hydrocarbon fuels.

Sulfur-tolerant and carbon-resistant catalysts

Methods for determining the presence or amount of a complex comprising a first and second molecular entity are provided, preferably an sFlt-1:PlGF complex. A determination of the presence or amount of the complex can be used in methods for predicting, detecting, monitoring a disease, or guiding therapy in respect to a disease such as vascular, vascular-related disease, cardiac, cardiac-related disease, cancer, cancer-related disease, preeclampsia, and preeclampsia-related disease. Determining sFlt-1:angiogenic factor complex is particularly useful for predicting and detecting preeclampsia in early stages of gestation and in stages of the disease where clinical evaluation may be uninformative.

Determination of sFlt-1:angiogenic factor complex

The present invention generally relates to high rate adsorbents and a method for their manufacture involving the steps of component mixing, extrusion, spheronization and calcination. The component mixing can involve both dry mixing in addition to wet mixing of an adsorbent with a binder, if required, and a fluid such as water. The paste so formed from the mixing stage is extruded to produce pellets which are optionally converted to beads by spheronization using in one embodiment, a marumerizer. The product is harvested and calcined to set any binder or binders used and/or burn out any additives or processing aids. This basic manufacturing scheme can be augmented by extra processing steps including ion exchange and activation to alter the composition of the adsorbents, as required.

Gas separation adsorbents and manufacturing method

Disclosed herein are compositions and methods comprising two or more proteins in which at least one of the proteins has been altered to reduce their mutual recognition and binding. Such compositions are useful as reference, calibrators or controls in methods and assays for determining the amount of one or more of the proteins that may be present in a sample of interest or in confirming the presence of one or more of the proteins in the sample. More particularly, it relates to compositions and methods comprising altered placental growth factor-1 (PlGF-1) and soluble fms-like tyrosine kinase (sFlt-1) and methods for determining the amount or confirming the presence of sFlt-1 and/or PlGF-1 in a sample of interest.

Calibrator/control for simultaneous assay of proteins capable of complexing with one another

Growing community of inventors

Raritan, NJ, United States of America

Jian Zheng